Anti-inflammatory medications fall into several broad categories, each working through a different mechanism and carrying a distinct risk profile. The most familiar are nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and naproxen, but the full landscape includes corticosteroids, disease-modifying antirheumatic drugs, biologic therapies, and even some medications not traditionally thought of as anti-inflammatory at all. Choosing among them involves weighing how much inflammation you need to control, how long you need to control it, and which organs you can least afford to stress.
NSAIDs and How They Work
NSAIDs are by far the most widely used anti-inflammatory drugs. The group includes over-the-counter staples like ibuprofen, naproxen, and aspirin, as well as prescription options like diclofenac, meloxicam, indomethacin, and celecoxib. They all share the same basic mechanism: blocking enzymes called cyclooxygenases (COX-1 and COX-2) that your body uses to produce prostaglandins, the chemical messengers that drive pain, swelling, and fever at the site of injury or infection.1PubMed Central. Effects of Nonsteroidal Anti-Inflammatory Drugs at the Molecular Level The two COX enzymes do different jobs. COX-1 runs all the time, helping maintain the stomach lining and supporting kidney blood flow. COX-2 ramps up during inflammation. Most older NSAIDs block both enzymes to varying degrees, which is why they relieve inflammation but also irritate the gut.2PubMed. Cyclooxygenases as the principal targets for the actions of NSAIDs
The distinction between “selective” COX-2 inhibitors (like celecoxib) and “traditional” NSAIDs is less clean than it sounds. Diclofenac, technically a traditional NSAID, has about the same degree of COX-2 selectivity as celecoxib. Meanwhile, naproxen and indomethacin lean more toward COX-1 inhibition.3Prescriber Update. NSAIDs and cardiovascular risk So when you hear that COX-2 inhibitors are “gentler on the stomach,” that is a generalization with real exceptions depending on which specific drug you are comparing.
Gut Risks With NSAIDs
The most common side effects of NSAIDs involve the digestive tract. They can cause heartburn, stomach pain, peptic ulcers, and in serious cases, bleeding or perforation of the stomach or small bowel.4PubMed Central. Non-steroidal anti-inflammatory drugs and the gastrointestinal tract These problems are not limited to long-term users; even short courses at standard doses carry some risk, especially in people who are older, who drink alcohol regularly, or who take blood thinners.
If you need an NSAID but have a history of stomach trouble, several strategies reduce the danger. Using the lowest dose that works, for the shortest time possible, is the baseline recommendation. Adding a proton pump inhibitor (a medication like omeprazole) substantially lowers the risk of ulcers and upper GI bleeding. Switching to a COX-2-selective NSAID is roughly as protective as adding a proton pump inhibitor for both upper and lower GI complications.4PubMed Central. Non-steroidal anti-inflammatory drugs and the gastrointestinal tract Testing for and treating Helicobacter pylori infection can also help if you have not taken NSAIDs before, since the combination of H. pylori and NSAIDs multiplies ulcer risk considerably.5PubMed Central. Nonsteroidal Anti-Inflammatory Drug-Induced Gastroduodenal Bleeding: Risk Factors and Prevention Strategies
Heart and Kidney Risks With NSAIDs
All prescription NSAIDs in the United States carry a black-box warning about cardiovascular risk, including heart attack and stroke.6PubMed Central. A review of the benefits and risks of nonsteroidal anti-inflammatory drugs in the management of mild-to-moderate osteoarthritis A large meta-analysis of observational studies found that both COX-2 inhibitors and traditional NSAIDs raise the relative risk of cardiovascular events, with COX-2 inhibitors slightly higher at about a 22% increase versus roughly 18% for nonselective NSAIDs.7PubMed. Cardiovascular Risk of Nonsteroidal Anti-inflammatory Drugs and Classical and Selective Cyclooxygenase-2 Inhibitors: A Meta-analysis of Observational Studies Among individual drugs, naproxen stands out for having a comparatively neutral cardiovascular profile, while ibuprofen and diclofenac tend to carry more risk.6PubMed Central. A review of the benefits and risks of nonsteroidal anti-inflammatory drugs in the management of mild-to-moderate osteoarthritis One practical wrinkle: ibuprofen can blunt the antiplatelet effect of low-dose aspirin, which matters if you take aspirin for heart protection. Naproxen does not appear to interfere in the same way.
Kidney damage is the third major concern. Prostaglandins help maintain blood flow to the kidneys, so blocking them with NSAIDs can trigger acute kidney injury, especially in people who are dehydrated, elderly, or already have heart or liver problems. Chronic NSAID use has also been linked to a gradual decline in kidney function and, less commonly, to interstitial nephritis, an inflammatory reaction inside the kidney tissue itself.8PubMed Central. Kidney damage from nonsteroidal anti-inflammatory drugs-Myth or truth? Review of selected literature People taking multiple medications at the same time, particularly combinations of diuretics, blood-pressure drugs, and NSAIDs, face the highest kidney risk.
Topical NSAIDs as a Lower-Risk Alternative
If your inflammation is in a joint or muscle close to the skin surface, topical NSAID formulations deserve a serious look. Diclofenac gel, for instance, delivers anti-inflammatory relief to the tissue directly underneath it while producing dramatically less drug in the bloodstream. In a study comparing topical diclofenac gel to the oral version, systemic exposure from the gel was five to seventeen times lower. The topical form did not inhibit platelet function and caused fewer gastrointestinal side effects; the adverse events that did occur were mild skin reactions at the application site.9PubMed. Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers
A pooled safety analysis of patients with osteoarthritis confirmed this pattern at scale: oral diclofenac was associated with significantly greater increases in liver enzymes and creatinine, and greater decreases in kidney function markers, compared to the topical solution.10PubMed Central. Diclofenac topical solution compared with oral diclofenac: a pooled safety analysis Topical NSAIDs are not a good fit for widespread inflammation or deep internal joints like the hip, but for knees, hands, and elbows, they offer real anti-inflammatory potency with a much smaller systemic footprint.
Corticosteroids
When NSAIDs are not strong enough, corticosteroids are often the next step. Prednisone, methylprednisolone, dexamethasone, and hydrocortisone are among the most prescribed. They also come as inhalers for asthma, creams for skin conditions, and injections for inflamed joints. Unlike NSAIDs, which target one pathway, corticosteroids suppress inflammation on a much broader scale. They enter cells, bind to receptors in the cytoplasm, and travel to the nucleus, where they effectively shut down the activity of multiple inflammatory genes at once by interfering with the transcription factors that switch those genes on.11PubMed. Anti-inflammatory actions of glucocorticoids: molecular mechanisms The result is a powerful, rapid reduction in swelling, redness, and immune-cell activity.
That breadth is both the advantage and the liability. A short course of oral prednisone for a severe asthma flare or a poison-ivy reaction is generally manageable. But prolonged systemic use, especially at higher doses, leads to a long list of complications: bone loss, high blood sugar, weight gain and fat redistribution (the characteristic “moon face”), elevated blood lipids, mood and sleep disturbances, adrenal suppression, and weakened immune defenses.12PubMed Central. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy Infection risk is a particularly serious concern. At higher doses taken for more than a month, corticosteroids substantially increase the risk of opportunistic infections including certain fungal, viral, and bacterial infections that healthy immune systems usually keep in check.13Annals of Allergy, Asthma & Immunology. Systemic Corticosteroids: Immunologic Mechanisms and Infectious Complications – Section: Infectious Complications In patients with inflammatory bowel disease, for example, corticosteroids raised the risk of invasive fungal infections more than threefold compared to anti-TNF biologic drugs.14Crohn’s and Colitis 360. Corticosteroids Increase the Risk of Invasive Fungal Infections More Than Tumor Necrosis Factor-Alpha Inhibitors in Patients with Inflammatory Bowel Disease
For these reasons, corticosteroids are best used as a bridge: they knock inflammation down fast while a slower-acting therapy takes hold, and then they are tapered off as quickly as the disease allows. Localized forms (joint injections, topical creams, inhaled steroids for the lungs) deliver the drug where it is needed and produce far fewer systemic effects.
Disease-Modifying Drugs and Biologics
For chronic inflammatory diseases like rheumatoid arthritis, psoriasis, and inflammatory bowel disease, doctors often turn to medications that go beyond symptom relief and try to alter the disease process itself. These fall into two broad camps.
The first camp is conventional synthetic disease-modifying drugs, with methotrexate as the most established example. Methotrexate was originally a cancer drug, but at the much lower doses used for autoimmune diseases, it works through a different mechanism. The most widely accepted explanation is that it increases levels of adenosine, a naturally occurring molecule that, when it binds to receptors on immune cells, pushes the immune system toward a calmer, less inflammatory state.15PubMed Central. Methotrexate mechanism in treatment of rheumatoid arthritis In practice, methotrexate is cheap, well-studied, and often the first drug prescribed for rheumatoid arthritis. Its downsides include liver stress (regular blood tests are standard), nausea, mouth sores, and the need to avoid alcohol and pregnancy while taking it.
The second camp is biologic therapies, which are engineered proteins designed to neutralize specific inflammatory molecules. The first wave targeted tumor necrosis factor alpha (TNF-α), a cytokine that drives inflammation in many autoimmune conditions. Anti-TNF drugs like adalimumab and infliximab have substantially improved outcomes in rheumatoid arthritis, psoriasis, Crohn’s disease, and ankylosing spondylitis.16PubMed. Pharmacological therapy of spondyloarthritis Newer biologics target other inflammatory signals: interleukin-6, interleukin-17, interleukin-23, and others.17PubMed Central. Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations
Because biologics suppress specific arms of the immune system, infection is the chief worry. TNF-α inhibitors carry a well-documented risk of reactivating latent tuberculosis. Among anti-TNF drugs, adalimumab and infliximab carry the highest relative risks for TB reactivation.18PubMed. Biologic Agents and Tuberculosis This is why TB screening with a skin test or blood test is required before starting any TNF inhibitor. The newer biologics that target interleukins rather than TNF appear considerably safer on the tuberculosis front: a study following patients with latent TB found zero reactivation cases among those treated with anti-IL-17, anti-IL-23, or anti-IL-12/23 drugs over a median follow-up of about four years.19PubMed Central. Risk of Reactivation of Latent Tuberculosis in Psoriasis Patients on Biologic Therapies: A Retrospective Cohort from a Tertiary Care Centre in Northern Italy
Colchicine
Colchicine occupies an unusual niche. It has been used for centuries to treat gout flares, and more recently it has found a role in pericarditis (inflammation of the sac around the heart) and possibly in cardiovascular disease prevention. Rather than blocking prostaglandins or suppressing genes, colchicine works by binding to microtubules inside white blood cells, which disrupts the cells’ ability to migrate to inflamed tissue and to release inflammatory signals. It also inhibits the production of factors that recruit more immune cells to the site.20PubMed Central. Effects of colchicine on pericardial diseases: a review of the literature and current evidence Its side effects are mainly gastrointestinal — diarrhea, nausea, and cramping — and the margin between an effective dose and a toxic one is narrow, which is why careful dosing matters.
Medications With Anti-Inflammatory Side Benefits
Some drugs not classified as anti-inflammatories still measurably reduce inflammation, which may contribute to their clinical benefits. Statins, prescribed primarily to lower cholesterol, are the leading example. Beyond their lipid-lowering effects, statins reduce circulating levels of C-reactive protein (CRP), a widely used marker of systemic inflammation.21PubMed Central. The Anti-Inflammatory Effects of Statins on Coronary Artery Disease: An Updated Review of the Literature A large meta-analysis of randomized controlled trials found that statins lowered CRP by an average of about 0.65 mg/L compared to placebo.22Cardiovascular Research. Effect of lipid-lowering therapies on C-reactive protein levels: a comprehensive meta-analysis of randomized controlled trials – Section: Results
This matters because people who achieve low CRP levels after starting a statin tend to have better cardiovascular outcomes than those with higher CRP, even when their cholesterol levels are similar.23PubMed. C-reactive protein levels and outcomes after statin therapy The finding suggests that part of the benefit people get from statins comes from cooling inflammation in artery walls, not just from clearing cholesterol. This does not mean statins should be taken purely as anti-inflammatory drugs, but it does help explain why their real-world cardiovascular benefits sometimes exceed what cholesterol reduction alone would predict.
Supplements With Anti-Inflammatory Evidence
Omega-3 fatty acids, curcumin (the active compound in turmeric), and ginger are the supplements with the strongest clinical evidence for reducing inflammatory markers, though “strongest” is relative — the effects are mild compared to prescription drugs.
In a trial comparing three dietary supplement interventions, omega-3 fatty acids significantly reduced TNF-α, one of the major inflammatory cytokines.24PubMed Central. The anti-inflammatory effects of three different dietary supplement interventions – Section: Results Omega-3s also serve as raw material for the body to produce specialized pro-resolving mediators, a topic covered below. A systematic review and meta-analysis of curcumin supplementation across randomized controlled trials found reductions in CRP, interleukin-6, and TNF-α, with an increase in the anti-inflammatory cytokine IL-10.25Nutrition Reviews. Anti-inflammatory effects of oral supplementation with curcumin: a systematic review and meta-analysis of randomized controlled trials Ginger has also shown effects on inflammatory enzymes and signaling pathways in the context of rheumatoid arthritis research.26PubMed Central. Over-the-Counter Anti-inflammatory Supplements for Adjunctive Rheumatoid Arthritis Therapy: A Comprehensive Narrative Review
A realistic way to think about these supplements: they can modestly shift inflammatory markers in the right direction over weeks of consistent use, and they may complement conventional treatment, but they are not replacements for NSAIDs or corticosteroids when inflammation is acute or severe. Curcumin also has notoriously poor absorption on its own, which is why most formulations add piperine (black pepper extract) or use lipid-based delivery systems to improve uptake. If you are on blood thinners or have gallbladder issues, check with a pharmacist before adding curcumin or high-dose ginger, since both can interact with anticoagulants.
Special Considerations for Older Adults
Age changes the risk calculus for almost every anti-inflammatory drug. Older adults are more likely to have reduced kidney function, cardiovascular disease, and a thinner stomach lining — precisely the systems that NSAIDs stress the most.27PubMed Central. A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly They also tend to take more medications simultaneously, raising the chance of harmful drug interactions. A common dangerous combination in older patients involves an NSAID, a diuretic, and a blood-pressure-lowering drug (often called the “triple whammy”), which can quickly impair kidney function.
Corticosteroids are particularly problematic for older adults because they accelerate bone loss in a population already at elevated fracture risk, and they raise blood sugar in people who may be prediabetic or managing diabetes. Topical NSAIDs, acetaminophen (which relieves pain but has limited anti-inflammatory action), and non-pharmacological approaches like physical therapy often become the preferred first-line options for managing osteoarthritis pain in this age group.
How the Body Resolves Inflammation on Its Own
Most anti-inflammatory drugs work by blocking the signals that start inflammation. But the body also has an active system for shutting inflammation down once it has done its job, and understanding it opens the door to a genuinely different kind of therapy. The resolution phase is driven by a family of molecules called specialized pro-resolving mediators (SPMs), which include resolvins, protectins, and maresins. These are produced from omega-3 fatty acids like DHA and EPA.28PubMed Central. Resolvins, Protectins, and Maresins: DHA-Derived Specialized Pro-Resolving Mediators, Biosynthetic Pathways, Synthetic Approaches, and Their Role in Inflammation
Instead of simply blocking inflammation, SPMs actively promote the cleanup: they signal immune cells to stop releasing inflammatory chemicals, encourage the clearance of debris and dead cells, reduce pain signaling, and support tissue repair.29PubMed Central. Specialized Pro-Resolving Mediator Network: An Update on Production and Actions The concept is appealing because chronic inflammatory diseases may not just involve too much inflammation starting; they may involve too little resolution happening. Drugs that mimic or boost SPMs could, in theory, resolve inflammation without suppressing the immune system the way corticosteroids and biologics do. So far, turning that theory into approved drugs has been slow going. Very few SPM-based compounds have reached clinical trials, partly because these molecules are fragile and hard to deliver in stable pharmaceutical forms.30PubMed Central. New Advances in Targeting the Resolution of Inflammation: Implications for Specialized Pro-Resolving Mediator GPCR Drug Discovery Still, it is one of the more interesting frontiers in inflammatory disease research and one reason omega-3 intake keeps showing up in anti-inflammatory conversations — your body uses those fats as the raw ingredients for resolution.